title: Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease.
abstract: OBJECTIVE
  To estimate the prevalence of cardiovascular events in Primary biliary cirrhosis (PBC) and to determine whether this risk is higher within specific subgroups of patients with PBC.
  
  
  METHODS
  We included 180 patients with PBC (cases) and 151 patients seen for HCV infection (controls). Medical records were reviewed and statistical analyses were performed as appropriate.
  
  
  RESULTS
  When compared to controls, PBC patients were older, leaner and had higher serum levels of total cholesterol, high density lipoprotein and low density cholesterol. There were more females in the PBC group (91.7% vs 43%, P < 0.001). More control subjects had smoked than the PBC patients (63.6% vs 35%, P < 0.001). The prevalence of hypertension, diabetes, coronary artery disease and stroke was similar between the two groups. Seven percent of controls and 10% of cases developed any type of cardiovascular disease (P = 0.3). Only 36.7% were asymptomatic at diagnosis. Three cardiovascular events were documented among asymptomatic patients (4.5%) and fifteen among symptomatic patients (13.2%; P = 0.06). Among PBC patients with fatigue, 10 (13.5%) had a cardiovascular event compared to 7 (6.7%) among patients without fatigue (P = 0.1).
  
  
  CONCLUSIONS
  Asymptomatic PBC patients do not have a greater frequency of cardiovascular disease; nor do patients suffering with fatigue.
authors: Iliana Doycheva, Department of Medicine, University of Florida, Gainesville, FL 32610, United States.
authors: Iliana
authors: I
authors: Doycheva
authors: Chaoru
authors: C
authors: Chen
authors: Jen-Jung
authors: JJ
authors: Pan
authors: Cynthia
authors: C
authors: Levy
references: Gut. 2006 Dec;55(12):1795-800
references: 16632556
references: Gut. 2010 Apr;59(4):508-12
references: 20332522
references: Lancet. 2003 Jul 5;362(9377):53-61
references: 12853201
references: Hepatology. 2000 May;31(5):1055-60
references: 10796879
references: Mayo Clin Proc. 1994 Oct;69(10):923-9
references: 7934188
references: Gut. 2004 Jun;53(6):865-70
references: 15138215
references: Liver. 1999 Apr;19(2):115-21
references: 10220741
references: Hepatology. 2007 Jun;45(6):1496-505
references: 17538969
references: Hepatology. 1995 Jan;21(1):89-95
references: 7806174
references: Atherosclerosis. 2010 Mar;209(1):178-83
references: 19782361
references: Gastroenterology. 1985 Dec;89(6):1266-78
references: 4054519
references: J Lipid Res. 2004 Nov;45(11):2116-22
references: 15314101
references: Hepatology. 1992 May;15(5):858-62
references: 1568727
references: Liver Int. 2010 Feb;30(2):251-8
references: 19922590
references: Gut. 2006 Apr;55(4):536-41
references: 16299032
references: Hepatology. 2005 Nov;42(5):1194-202
references: 16250040
references: Gut. 2002 Aug;51(2):265-9
references: 12117892
references: Scand J Gastroenterol. 1997 Jan;32(1):77-83
references: 9018771
references: N Engl J Med. 1990 Jun 14;322(24):1700-7
references: 2342536
references: Hepatology. 2009 Oct;50(4):1030-7
references: 19787818